PTH Attenuation Trial in Hemodialysis-1
Condition: Secondary Hyperparathyroidism Interventions: Drug: PLS240; Drug: Placebo; Drug: Open-Label Extension PLS240 Sponsors: Pathalys Pharma; Launch Therapeutics Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials